Organon & Co. (OGN)

NYSE: OGN · Real-Time Price · USD

13.76

+0.02 (0.11%)

Oct 15, 2026, 1:09 PM EDT - Market open

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Women's Health Revenue	1.64B	1.75B	1.78B
Biosimilars Revenue	745.00M	691.00M	662.00M
Established Brands Revenue	3.68B	3.69B	3.85B
Other Product Group Revenue	68.00M	82.00M	115.00M
Revenue (Total)	6.13B	6.22B	6.40B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States Revenue	1.53B	1.60B	1.57B
Europe and Canada Revenue	1.67B	1.62B	1.76B
Asia Pacific and Japan Revenue	957.00M	1.00B	1.05B
China Revenue	823.00M	829.00M	847.00M
Latin America, Middle East, Russia and Africa Revenue	1.06B	1.07B	1.03B
Other International Revenue	83.00M	93.00M	137.00M
International Revenue	4.59B	4.61B	4.83B
Revenue (Total)	6.13B	6.22B	6.40B